Products and Services

Aptar CSP Technologies has announced an expansion of its cGMP manufacturing capacity for clinical packaging of dry powder inhalation capsules using the company's Activ-Blister technology. Aptar CSP cited growing demand for the technology for both oral dose and DPI capsules as the reason for launching the new site in New Jersey. According to the company, the site will … [Read more...] about Aptar CSP expands capacity for clinical packaging of DPI capsules

3P innovation has announced that it is now offering new filling technology in its custom-built DPI filling systems that is based on equipment originally patented by GSK for high-speed filling of Diskus dry powder inhalers. The company notes that its founder, Tom Bailey, led development of filling technology for the original Diskus filling system which later was used … [Read more...] about 3P Innovation launches new filling system for generic Diskus and Ellipta DPI products

Intertek has announced a 6,000 sq ft expansion of its facility in Melbourn, UK to add laboratory space for characterization of large molecules for inhalation. In 2019, the company acquired a facility that doubled its total lab space in Melbourn to 40,000 sq ft at that time; the new expansion brings the total area to 46,000 sq ft. The company, which sponsors an … [Read more...] about Intertek announces expansion of its Melbourn, UK lab to add space for inhaled biologics testing

Inhalation CDMO Bespak announced that it has completed an independently verified life cycle assessment to evaluate environmental impacts associated with materials and manufacturing of its BK357 metered dose inhaler valve. The company said that the assessment is part of its sustainability effort, which also has included the addition of manufacturing capability for MDIs … [Read more...] about Bespak announces completion of life cycle assessment for its BK357 MDI valve

Swedish DPI developer Iconovo has announced that it will lay off about 10 employees as it switches its focus to commercialization of its existing dry powder inhalation platforms, including the ICOres reservoir-based DPI, the ICOpre generic version of Ellipta, and the ICOone single use device in both inhaled and nasal versions. Instead of continuing to do all … [Read more...] about Iconovo announces it will downsize and focus on commercialization of existing DPI platforms

AptarGroup announced that its subsidiary Nanopharm is initiating a clinical study to validate the SmartTrack in-vitro-in-silico modeling platform as an alternative to clinical endpoint studies for determining bioequivalence of inhaled drug products. The study will also collect PK data for validation of Nanopharm's Simhalation physically-based pharmacokinetic (PBPK) … [Read more...] about Nanopharm announces clinical study to validate SmartTrack platform for demonstration of BE for inhaled drug products

According to Iconovo, the European Patent Office has indicated that it will approve a patent application for an additional patent that will provide protection for Iconovo's ICOres reservoir-based dry powder inhaler platform until 2038. ICOres is already covered by patents in a number of countries, including Japan, China, and the US. Iconovo CEO Johan Wäborg … [Read more...] about Iconovo gets new European patent covering its ICOres inhaler platform

Irish nebulization specialist Aerogen has announced the official opening of its India headquarters in New Delhi. According to Aerogen, the New Delhi office includes a library and recreation space in addition to offices for sales, marketing, and clinical personnel. The company said that it expects to expand staff at the location from 14 employees to 30 within 5 years … [Read more...] about Aerogen opens India headquarters